Filing Flows › Vistagen Therapeutics (VTGN) › Q1 FY27 › vs Q4 FY26
Vistagen Therapeutics (VTGN) Q1 FY27 vs Q4 FY26 (quarter over quarter)
Vistagen Therapeutics's revenue rose $1.0M (+217%) from $465K in Q4 FY26 to $1.5M in Q1 FY27.
Vistagen Therapeutics, Q1 FY27: revenue $1.5M (+505% year over year), operating margin -904.3%, net loss $13.0M, operating cash flow −$14.7M. The chart draws each line against Q4 FY26, the increases inside each band.
Every line
| Line | Q1 FY27 | Q4 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5M | $465K | $1.0M | +217% |
| Other income, net | $318K | $450K | −$132K | -29% |
| Net loss | $13.0M | $16.3M | −$3.2M | -20% |
| Costs & expenses | $14.8M | $17.2M | −$2.4M | -14% |
| Operating costs | $14.8M | $17.2M | −$2.4M | -14% |
| Research & development | $10.9M | $13.1M | −$2.2M | -16% |
| General & admin | $3.9M | $4.1M | −$204K | -5% |
| Operating cash sources | $15.8M | $17.1M | −$1.4M | -8% |
| Depreciation & amortization | $52K | $52K | $0 | 0% |
| Share-based compensation | $991K | $889K | $102K | +11% |
| Cash used in operations | $14.7M | $16.2M | −$1.5M | -9% |
| Net loss absorbed | $13.0M | $16.3M | −$3.2M | -20% |
| Working capital & other | $2.7M | $867K | $1.9M | +214% |
Questions
How much did Vistagen Therapeutics's revenue grow quarter over quarter in Q1 FY27?
Vistagen Therapeutics's revenue rose $1.0M (+217%) from $465K in Q4 FY26 to $1.5M in Q1 FY27.